We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
Cap. Flow
-$1.62B
Cap. Flow %
-9.46%
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$62M
2
AMZN icon
Amazon
AMZN
+$53.3M
3
CVS icon
CVS Health
CVS
+$40.3M
4
PYPL icon
PayPal
PYPL
+$34.8M
5
MCD icon
McDonald's
MCD
+$34.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$56.8M
2
EXE
Expand Energy Corp
EXE
+$43.4M
3
CHTR icon
Charter Communications
CHTR
+$42.4M
4
CMCSA icon
Comcast
CMCSA
+$40.3M
5
MA icon
Mastercard
MA
+$37.3M

Sector Composition

Rank Sector Weight
1 Financials 12.54%
2 Technology 11.9%
3 Consumer Discretionary 9.76%
4 Healthcare 8.91%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLND icon
4176
Blend Labs
BLND
$369M
$94 ﹤0.01%
65
-10,635
-99% -$19.1K
LDTCW
4177
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$89 ﹤0.01%
+5,186
New +$109
QDROW
4178
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$45 ﹤0.01%
18,025
EPHYW
4179
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$25 ﹤0.01%
+10,831
New +$300
NKLA
4180
DELISTED
Nikola Corporation Common Stock
NKLA
-2,853
Closed -$238K
BINI
4181
DELISTED
Bollinger Innovations
BINI
0
NGNE icon
4182
Neurogene
NGNE
$719M
-306
Closed -$3.16K
IMUX icon
4183
Immunic
IMUX
$191M
-535
Closed -$14.6K
ALGS icon
4184
Aligos Therapeutics
ALGS
$43.9M
-1
Closed -$25
SOND
4185
DELISTED
Sonder
SOND
0
ARVL
4186
DELISTED
Arrival Ordinary Shares
ARVL
-2,000
Closed -$47.6K
ABG icon
4187
Asbury Automotive
ABG
$3.8B
-7,888
Closed -$1.19M
ABUS icon
4188
Arbutus Biopharma
ABUS
$911M
-10,726
Closed -$20K
ACB
4189
Aurora Cannabis
ACB
$181M
-19,626
Closed -$239K
ACHR icon
4190
Archer Aviation
ACHR
$5.01B
-94,900
Closed -$248K
ACLS icon
4191
Axcelis
ACLS
$4.15B
-35,665
Closed -$2.16M
ACRS icon
4192
Aclaris Therapeutics
ACRS
$844M
-8,109
Closed -$128K
ADC icon
4193
Agree Realty
ADC
$9.23B
-15,012
Closed -$1.01M
ADN
4194
DELISTED
Advent Technologies
ADN
-2,731
Closed -$251K
ADSK icon
4195
CALL
Autodesk
ADSK
$53.6B
-7,400
Closed -$1.38M
ADV icon
4196
Advantage Solutions
ADV
$361M
-698
Closed -$37K
ADVM
4197
DELISTED
Adverum Biotechnologies
ADVM
-1,438
Closed -$14K
AEP icon
4198
PUT
American Electric Power
AEP
$67B
-4,100
Closed -$354K
AFCG
4199
AFC Gamma
AFCG
$62.5M
-21,870
Closed -$229K
AGIO icon
4200
Agios Pharmaceuticals
AGIO
$1.97B
-46,593
Closed -$1.32M

Similar funds

Cubist Systematic Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.

  • Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
  • Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
  • Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
  • Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
  • Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
  • Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.